The HAX1 Gene Neutropenia Severe Congenital Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the HAX1 gene, which are linked to Severe Congenital Neutropenia Type 3 (SCN3). This condition is a rare genetic disorder characterized by a marked decrease in the number of neutrophils, a type of white blood cell crucial for fighting off infections. Individuals with SCN3 are at a higher risk of recurrent infections, which can be life-threatening if not diagnosed and managed properly.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the HAX1 gene that are known to cause the disorder. This genetic test is critical for early diagnosis, allowing for timely intervention and management strategies to reduce the risk of infections and improve the quality of life for affected individuals.
The cost of the HAX1 Gene Neutropenia Severe Congenital Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to accurately diagnose this condition, guiding families and healthcare providers in making informed decisions regarding the care and treatment of patients with SCN3.
The VPS45 Gene Neutropenia Severe Congenital Type 5 Autosomal Recessive Genetic Test is a specific diagnostic tool designed to detect mutations in the VPS45 gene, which are responsible for causing Severe Congenital Neutropenia Type 5 (SCN5). This condition is a rare autosomal recessive disorder characterized by a severe reduction in the number of neutrophils, a type of white blood cell crucial for fighting infections. Patients with SCN5 often suffer from recurrent bacterial infections from infancy, which can be life-threatening if not diagnosed and managed properly.
The test is conducted by DNA Labs UAE, a facility known for its advanced genetic testing capabilities. By analyzing the patient's DNA sample, usually obtained from a blood draw, the test can identify specific mutations in the VPS45 gene that lead to the development of SCN5. This precise genetic insight is vital for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions.
The cost of the VPS45 Gene Neutropenia Severe Congenital Type 5 Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. Although the price might seem significant, the test provides crucial information for the effective management of the condition, potentially improving the quality of life and prognosis for affected individuals.
The "RPS7 Gene Diamond-Blackfan Anemia Type 8 Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the RPS7 gene, which are associated with Diamond-Blackfan Anemia (DBA) Type 8. DBA is a rare genetic disorder that affects the bone marrow, leading to reduced production of red blood cells and resulting in anemia. The RPS7 gene plays a crucial role in the development and function of ribosomes, which are essential for protein synthesis in cells.
This genetic test is crucial for individuals suspected of having DBA Type 8, as it can confirm the diagnosis, allowing for appropriate management and treatment strategies to be implemented. It involves collecting a DNA sample, usually through a blood draw, which is then analyzed for specific mutations in the RPS7 gene that are indicative of the disorder.
The cost of the RPS7 Gene Diamond-Blackfan Anemia Type 8 Genetic Test at DNA Labs UAE is 4400 AED. This investment in testing is vital for affected individuals and their families, as it not only aids in the diagnosis but also helps in understanding the genetic basis of the condition, which can be important for family planning and determining the risk for future offspring.
The RPS10 Gene Diamond-Blackfan Anemia Type 9 Genetic Test is a specialized diagnostic examination offered at DNA Labs UAE, designed to identify mutations in the RPS10 gene, which are associated with Diamond-Blackfan Anemia (DBA) Type 9. DBA is a rare, inherited bone marrow failure disorder characterized by an inability to produce sufficient red blood cells, leading to anemia and various other physical abnormalities. The RPS10 gene plays a crucial role in the production of ribosomes, which are essential for protein synthesis in cells, including those responsible for red blood cell formation.
This genetic test is critical for individuals suspected of having DBA Type 9 or for those with a family history of the condition, as it can provide definitive diagnosis, enabling targeted treatment and management strategies. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for the presence of mutations in the RPS10 gene.
The cost of the RPS10 Gene Diamond-Blackfan Anemia Type 9 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic mutations associated with the condition, providing invaluable information for affected individuals and their families. Early diagnosis through this genetic test can significantly impact the management of DBA, improving the quality of life and prognosis for those affected by this rare disorder.
The COX4I2 Gene Dyserythropoietic Anemia Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the COX4I2 gene, which are implicated in causing congenital dyserythropoietic anemia. This condition is a rare form of anemia characterized by ineffective erythropoiesis, leading to a range of symptoms from mild to severe, including fatigue, pallor, and in some cases, skeletal abnormalities and gallstones. Early and accurate diagnosis through genetic testing is crucial for the management and treatment of the condition. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic variations in the COX4I2 gene that may result in the disorder, providing valuable information for clinicians to devise an appropriate treatment plan. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test is a significant step towards personalized medicine, offering hope and improved care for patients suffering from congenital dyserythropoietic anemia.
The C15orf41 gene plays a crucial role in human genetics, particularly in the context of dyserythropoietic anemia congenital type 1B, a rare blood disorder characterized by ineffective erythropoiesis leading to anemia. The condition is genetically inherited and involves abnormalities in red blood cell formation, causing various symptoms such as fatigue, pallor, and in severe cases, skeletal deformations and growth retardation.
A genetic test for this condition focuses on identifying mutations in the C15orf41 gene, which can confirm a diagnosis of dyserythropoietic anemia congenital type 1B. This is crucial for the management and treatment of the condition, as well as for genetic counseling of affected families.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect and interpret mutations in the C15orf41 gene. This test is essential for individuals showing symptoms of the condition or those with a family history, providing them with critical information for managing their health.
The KIF23 gene dyserythropoietic anemia congenital type 3 genetic test is a specialized diagnostic tool designed to identify mutations in the KIF23 gene, which are associated with congenital dyserythropoietic anemia type 3 (CDA III). This condition is a rare form of anemia characterized by ineffective erythropoiesis, leading to a range of symptoms from mild to severe, including fatigue, pallor, and jaundice. The KIF23 gene plays a crucial role in cytokinesis during cell division, and mutations in this gene can disrupt normal red blood cell production, contributing to the anemia seen in CDA III.
The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed to accurately detect mutations in the KIF23 gene. This test is crucial for individuals suspected of having CDA III, as it can confirm the diagnosis, allowing for appropriate management and treatment plans to be devised. Moreover, identifying the specific genetic mutation can provide valuable information for family planning and the assessment of risk in future offspring.
The KLF1 Gene Dyserythropoietic Anemia Congenital Type 4 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the KLF1 gene, which are implicated in the development of Congenital Dyserythropoietic Anemia Type 4 (CDA Type 4). CDA Type 4 is a rare genetic disorder characterized by anemia that stems from ineffective erythropoiesis - the process by which the bone marrow produces new red blood cells. Individuals with this condition may experience symptoms such as fatigue, pallor, jaundice, and in severe cases, organ damage due to iron overload from frequent blood transfusions.
The test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the KLF1 gene that are known to cause the disorder. This genetic test is crucial not only for the accurate diagnosis of CDA Type 4 but also for guiding treatment decisions and genetic counseling. It allows for a targeted approach to management, including monitoring for and addressing potential complications early.
At DNA Labs UAE, the cost for the KLF1 Gene Dyserythropoietic Anemia Congenital Type 4 Genetic Test is set at 4400 AED. The investment in this test can provide invaluable insights for affected individuals and their families, enabling a better understanding of the condition, its progression, and the most effective management strategies tailored to the genetic makeup of the patient.
The F2 Gene Dysprothrombinemia Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the F2 gene, which is responsible for the production of prothrombin (factor II) - a protein crucial for blood clotting. Dysprothrombinemia is a rare coagulation disorder characterized by abnormal blood clotting, which can lead to either excessive bleeding or thrombosis, depending on the nature of the mutation. The test is crucial for individuals with a family history of coagulation disorders or those exhibiting symptoms related to abnormal clotting. It involves analyzing the patient's DNA to detect specific genetic variations associated with the condition, providing valuable information for diagnosis, management, and treatment planning. The cost of the F2 Gene Dysprothrombinemia Genetic Test at DNA Labs UAE is 4400 AED, reflecting the comprehensive nature of the analysis and the expertise required to interpret the results accurately.
The EPOR Gene Erythrocytosis Familial Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the EPOR gene. These mutations are associated with Familial Erythrocytosis Type 1, a rare condition characterized by an increased number of red blood cells due to overproduction. This genetic anomaly leads to a high hemoglobin concentration, which can cause a range of symptoms from mild to severe, including headaches, dizziness, and an increased risk of thrombosis.
This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as early detection can lead to better management of the condition. Conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic diagnostics, the test ensures accuracy and reliability.
The cost of the EPOR Gene Erythrocytosis Familial Type 1 Genetic Test is set at 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the EPOR gene, providing essential information for the proper management and treatment of the condition.
